An interventional study of fiber in Cardiovascular Risk Factor, sponsored by Isfahan University of Medical Sciences. Completed. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-20.
Sponsored by Isfahan University of Medical Sciences · Not applicable, Interventional, and Treatment
This study was a parallel randomized controlled feeding trial conducted in overweight and obese participants who were attending the Nutrition Clinic in Isfahan, Iran. Inclusion criteria were as follows: women aged 18 to 50 years; body mass index (BMI) 25 kg/m2
; having noncommunicable diseases such as diabetes, hyperlipidemia, and hypertension; having no history of liver and renal disease, hormonal disorders, food allergy, and other special diseases; not taking specific medications affecting weight; willingness to introduce a dietary change to lose weight; and habitual daily consumption of fruits, vegetables, and whole grains. The exclusion criteria were the following: weight loss of more than 10% of body weight within the 6 months before registration in the study; attending a competitive sport; no consumption of fruits, vegetables, or whole grains habitually; abnormal thyroid hormone concentration; intake of drugs or supplementation that could affect energy expenditure or weight; and not following recommended diets or returning for following visits. Recruitment ran from January 2016 to July 2016. The sample size was calculated based on the standard formula (45):
by considering the Type 1 error (a) of 0.05 and Type 2 error (b) of 0.20 (power D 80%). Based on a previous study in Iranian women (46), we used a within-group BMI mean difference (d) of 2.5 kg/m2 and a standard deviation (SD) of 3.2 kg/m2
overweight or obese
Exclusion Criteria:
have any diseases
25 gram fiber from whole grain products and 10 gram fiber from fruits and vegetables
Dietary Supplement: fiber
25 gram fiber from fruits and vegetables as main supplier and the remaining 10 grams from whole grain sources
Dietary Supplement: fiber
17.5 gram fiber from whole grain and 17.5 gram fiber from fruits and vegetables
Dietary Supplement: fiber
the intervention of different sources of dietary fibers
change of weight
Weight was measured by using a digital scale to the nearest 100g while participants wearing light clothes ( Seca, Hamburg , Germany)
Time frame: 10 weeks
change of waist circumference
The narrowest part of Waist was considered for measuring waist circumference where is between the last rib and the iliac crest to the nearest 0.1 cm over light clothing .
Time frame: 10 weeks
change of BMI
BMI was calculated as body weight (Kg)/ height 2 (m).We used a standard mercury sphygmomanometer to measure participants
Time frame: 10 weeks
change of blood pressure
Blood pressure after resting for 15 minutes. The measurement was performed three times in the sitting position with 1 minute intervals and the average of three measurements was considered as final blood pressure.Systolic blood pressure was defined as the appearance of the first sound and diastolic blood pressure was defined as the disappearance of the sound.(Korotkoff phase 5).All Subjects were asked to avoid coffee, tea and all caffeine containing materials before blood pressure.
Time frame: 10 weeks
change of FBS
Fasting blood glucose was measured by enzymatic colorimetric method using glucose oxidase on the day of blood collection.Blood Specimens were centrifuged at 3000 rpm for 10 minutes in order to separate plasma and samples were stored at -70 C until analysis
Time frame: 10 weeks
change of lipid profiles
Total cholesterol level and serum TG analysis was done using a Selectra 2 auto-analyzer (Vital scientific, Spankeren ,The Netherlands.) by an enzymetic colorimetric method with cholesterol esterase and cholesterol oxidase and glycerol phosphate oxidase.(Parsazmoun,Tehran ,Iran). HDL-C determination was done after precipitation of apolipoprotein B containing lipoporotein withphosphotungstic acid. LDL-C was calculated by Friedewald ´s formula when the TAG level was lower than 400 mg/dl ; otherwise , LDL-C was determined by an enzymatic method
Time frame: 10 weeks
No study locations are listed for this record.
This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Isfahan University of Medical Sciences